C4 Therapeutics, Inc. revenue breakdown overview

C4 Therapeutics, Inc. revenue for the last year amounted to 35.58 M USD, the most of which — 35.58 M USD — came from its highest performing source at the moment, Targeted Protein Degradation, the year earlier bringing 20.76 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought C4 Therapeutics, Inc. 35.58 M USD, and the year before that — 20.76 M USD.